Jay R T. Adolacion

Jay R T. Adolacion

Auto-generated profile, based on publicly available information

Jay R T. Adolacion

University of Houston, University of the Philippines, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
ILIvan Liadi
Ivan Liadi
HSHarjeet Singh
Harjeet Singh
GRGabrielle Romain
Gabrielle Romain
NRNicolas Rey-Villamizar
Nicolas Rey-Villamizar
AMAmine Merouane
Amine Merouane
NVNavin Varadarajan
Navin Varadarajan
T cells genetically modified to express a CD19-specific chimeric antigen receptor (CAR) for the investigational treatment of B-cell malignancies comprise a heterogeneous population, and their ability to persist and participate in serial killing of tumor cells is a predictor of therapeutic success. We implemented Timelapse Imaging Microscopy in Nanowell Grids (TIMING) to provide direct evidence that CD4+CAR+ T cells (CAR4 cells) can engage in multikilling via simultaneous conjugation to multiple tumor cells. Comparisons of the CAR4 cells and CD8+CAR+ T cells (CAR8 cells) demonstrate that, although CAR4 cells can participate in killing and multikilling, they do so at slower rates, likely due to the lower granzyme B content. Significantly, in both sets of T cells, a minor subpopulation of individual T cells identified by their high motility demonstrated efficient killing of single tumor cells. A comparison of the multikiller and single-killer CAR+ T cells revealed that the propensity and kinetics of T-cell apoptosis were modulated by the number of functional conjugations. T cells underwent rapid apoptosis, and at higher frequencies, when conjugated to single tumor cells in isolation, and this effect was more pronounced on CAR8 cells. Our results suggest that the ability of CAR+ T cells to participate in multikilling should be evaluated in the context of their ability to resist activation-induced cell death. We anticipate that TIMING may be used to rapidly determine the potency of T-cell populations and may facilitate the design and manufacture of next-generation CAR+ T cells with improved efficacy. Cancer Immunol Res; 3(5); 473–82. ©2015 AACR. See related commentary by June, p. 470

1 March 2021 in iScience
Verified
Journal Article
Open access
JZJunying Zheng
Junying Zheng
WRWenjuan Ru
Wenjuan Ru
JAJay R. Adolacion
Jay R. Adolacion
MSMichael S. Spurgat
Michael S. Spurgat
XLXin Liu
Xin Liu
STShao-Jun Tang
Shao-Jun Tang
Microglia are ubiquitous central nervous system (CNS)-resident macrophages that maintain homeostasis of neural tissues and protect them from pathogen attacks. Yet, their differentiation in different compartments remains elusive. We performed single-cell RNA-seq to compare microglial subtypes in the cortex and the spinal cord. A multi-way comparative analysis was carried out on samples from C57/BL and HIV gp120 transgenic mice at two, four, and eight months of age. The results revealed overlapping but distinct microglial populations in the cortex and the spinal cord. The differential heterogeneity of microglia in these CNS regions was further suggested by their disparity of plasticity in response to life span progression and HIV-1 pathogenic protein gp120. Our findings indicate that microglia in different CNS compartments are adapted to their local environments to fulfill region-specific biological functions.

24 October 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
DCDimple Chavan
Dimple Chavan
JAJay R T. Adolacion
Jay R T. Adolacion
MCMary Crum
Mary Crum
Suman NandySuman Nandy
Suman Nandy
KLKyung Hyun Lee
Kyung Hyun Lee
Richard C. WillsonRichard C. Willson
Richard C. Willson

1 January 2012 in International Journal of Chemical Engineering and Applications
Verified
Journal Article
Closed access
CMCharlimagne Montealegre
Charlimagne Montealegre
EDEmerson R. Dionisio
Emerson R. Dionisio
LSLawrence V. Sumera
Lawrence V. Sumera
JAJay R T. Adolacion
Jay R T. Adolacion
RLRizalinda de Leon
Rizalinda de Leon

4 November 2015 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
GRGabrielle Romain
Gabrielle Romain
HSHarjeet Singh
Harjeet Singh
ILIvan Liadi
Ivan Liadi
JAJay R Adolacion
Jay R Adolacion
BRBadrinath Roysam
Badrinath Roysam
NVNavin Varadarajan
Navin Varadarajan

4 November 2015 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
MMMelisa Martinez-Paniagua
Melisa Martinez-Paniagua
CHCara Haymaker
Cara Haymaker
JAJay R Adolacion
Jay R Adolacion
LRLaszlo Radvanyi
Laszlo Radvanyi
PHPatrick Hwu
Patrick Hwu
NVNavin Varadarajan
Navin Varadarajan